References
- Behets, G J.; Verberckmoes, S C.; D'Haese, P C.; De Broe, M E. Lanthanum carbonate: a new phosphate binder. Curr. Opin. Nephrol. Hypertens. 2004, 13, 403–409. [PUBMED], [INFOTRIEVE], [CSA]
- Joy, M S.; Finn, W F. Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia. Am. J. Kidney Dis. 2003, 42 (1), 96–107. [PUBMED], [INFOTRIEVE], [CROSSREF]
- D'Haese, P C.; Spasovski, G B.; Sikole, A.; , et al. A multicenter study on the effects of lanthanum carbonate (Fosrenol™) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int. 2003, 63, S73–S78. [CROSSREF]
- Behets, G J.; Dams, G.; Vercauteren, S R.; Damment, S J.; Bouillon, R.; De Broe, M E.; D'Haese, P C. Does the phosphate binder lanthanum carbonate affect bone in chronic renal failure rats?J. Am. Soc. Nephrol. 2004, 15, 2219–2228. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Plone, M A.; Petersen, J S.; Rosenbaum, D P.; Burke, S K. Sevelamer, a phosphate-binding polymer, is a non-absorbed compound. Clin. Pharmacokinet. 2002, 41 (7), 517–523. [PUBMED], [INFOTRIEVE], [CSA]
- Tietz, N W.; Rinker, A D.; Shaw, L M. IFCC methods for the measurement of catalytic concentration of enzymes Part 5. IFCC method for alkaline phosphatase (orthophosphoric-monoester phosphohydrolase, alkaline optimum, EC 3.1.3.1). J. Clin. Chem. Clin. Biochem. 1983, 21 (11), 731–748. [PUBMED], [INFOTRIEVE]
- Bradford, M M. A rapid and sensitive method for the determination of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254. [PUBMED], [INFOTRIEVE]
- Hansen, A C. Atomic absorption spectrophotometry for calcium and magnesium in serum and urine. At. Absorpt. Newsl. 1973, 12 (5), 125–128.
- Bouillon, R.; De Moor, P.; Baggiolini, E G.; Uskokovic, M R. A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin. Chem. 1980, 26 (5), 562–567. [PUBMED], [INFOTRIEVE]
- Bouillon, R.; Kerkhove, P V.; De Moor, P. Measurement of 25-hydroxyvitamin D3 in serum. Clin. Chem. 1976, 22 (3), 364–368. [PUBMED], [INFOTRIEVE]
- Parfitt, A M.; Drezner, M K.; Glorieux, F H.; , et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee. J. Bone Miner. Res. 1987, 2 (6), 595–610. [PUBMED], [INFOTRIEVE]
- Lotz, M.; Zisman, E.; Bartter, F C. Evidence for a phosphorus-depletion syndrome in man. N. Engl. J. Med. 1968, 278 (8), 409–415. [PUBMED], [INFOTRIEVE]
- Nagano, N.; Miyata, S.; Obana, S.; , et al. Renal mineral handling in normal rats treated with sevelamer hydrochloride (Renagel), a non calcemic phosphate binder. Nephron 2001, 89 (3), 321–328. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cornell, C N.; Chung-Leddon, J. Osteomalacia and hypophosphatemia. Curr. Opin. Orthop. 1995, 6 (V), 14–19.
- Condon, J R.; Nassim, J R.; Rutter, A. Pathogenesis of rickets and osteomalacia in familial hypophosphatasemia. Arch. Dis. Child. 1971, 46 (247), 269–272. [PUBMED], [INFOTRIEVE]
- McClure, J.; Smith, P S. Oncogenic osteomalacia. J Clin Pathol 1987, 40 (4), 446–453. [PUBMED], [INFOTRIEVE]
- Boutsen, Y.; Devogelaer, J P.; Malghem, J.; Noel, H.; Nagant, D D. Antacid-induced osteomalacia. Clin. Rheumatol. 1996, 15 (1), 75–80. [PUBMED], [INFOTRIEVE], [CSA]
- Hoenderop, J G.; van der Kemp, A W.; Hartog, A.; , et al. Molecular identification of the apical Ca2 + channel in 1,25-dihydroxyvitamin D3-responsive epithelia. J. Biol. Chem. 1999, 274 (13), 8375–8378. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nagano, N.; Miyata, S.; Obana, S.; , et al. Sevelamer hydrochloride (Renagel), a non-calcemic phosphate binder, arrests parathyroid gland hyperplasia in rats with progressive chronic renal insufficiency. Nephrol. Dial. Transplant. 2001, 16 (9), 1870–1878. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]